Samir Khalil – Executive Director, PhRMA MEA

PhRMA MEA's Samir Khalil highlights some of the key trends at play across the Middle East and Africa's dynamic and fast-changing pharmaceutical ecosystem, including several wide-ranging national health transformation plans, the move towards health technology assessment (HTA), and the importance of maintaining robust intellectual property (IP) protection.  
We can improve access to medicines through market-based reforms that promote competition, modernizing the drug discovery and development process and moving to a system that prioritizes results for patients
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report